HPV E6 protein regulation of the hTERT promoter
HPV E6 protein regulation of the hTERT promoter
批准号:
7488862
负责人:
Richard Schlegel
金额:
$29.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-16 至 2009-06-30
关键词:
Applications GrantsBindingBinding SitesBiologicalBoxingCancer EtiologyCatalytic DomainCell Cycle ProteinsCell Differentiation processCell ProliferationCellsChromosomesDataDifferentiation and GrowthEventGene ExpressionGenesGenetic TranscriptionGoalsGrantHPV-High RiskHistone AcetylationHistone DeacetylaseHuman PapillomavirusIn VitroLaboratoriesLengthMaintenanceMalignant NeoplasmsMalignant neoplasm of cervix uteriMediatingMediator of activation proteinMolecularMultienzyme ComplexesNF-kappa BOncogene ProteinsOncogenicPapillomavirusPhenotypePlayProcessProtein OverexpressionProtein p53ProteinsPublishingRateRegulationRiskRoleTP53 geneTechniquesTelomeraseTransactivationTumor Suppressor ProteinsWomanZinc Fingersbasecell growthcell immortalizationchromatin immunoprecipitationgenetic regulatory proteinhuman RCN2 proteinhuman TERT proteinhuman UBE3A proteinin vivokeratinocytemalignant statemutantpromoterprotein functiontelomeretranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Worldwide, cervical cancer is the second leading cause of cancer in women and the "high risk" human papillomaviruses play a critical role in the genesis of this malignancy. The papillomaviruses encode two oncoproteins, E6 and E7, that are required for the initiation and maintenance of the malignant state as well as the induction of cell immortalization. Several of these biological activities appear related to the ability of E6 and E7 to degrade the cellular p53 and Rb tumor suppressor proteins, respectively. However, independent of its ability to degrade p53, E6 can induce cellular telomerase activity and, presumably, thereby maintain chromosome telomere length and continued cell proliferation. The rate-limiting event in cellular telomerase activity is the level of hTERT protein, the catalytic subunit of the enzyme complex. We and others have shown that the E6 protein transactivates the hTERT promoter, leading to an increase in hTERT protein and cellular telomerase activity. Our most recent studies indicate that the E6 protein associates with Myc protein and that they both bind and cooperatively activate the hTERT promoter. Interestingly, only the "high risk" E6 proteins bind the hTERT promoter, further supporting the correlation between induction of telomerase and cell immortalization. The current proposal investigates the mechanism by which E6 associates with Myc, binds the hTERT promoter, and facilitates gene transcription. In addition, we will examine whether E6 augments other Myc-regulated genes and whether Myc can mimic a subset of E6-specific cellular phenotypes. The overall goal of the grant is to gain an understanding of the role of E6 in regulating gene transcription, cell growth and cell differentiation.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.ppat.1003284
发表时间:
2013
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[Miller J, Dakic A, Chen R, Palechor-Ceron N, Dai Y, Kallakury B, Schlegel R, Liu X]
通讯作者:
Liu X
Is HPV-18 present in human breast cancer cell lines?
人类乳腺癌细胞系中是否存在 HPV-18?
DOI:
10.1038/sj.bjc.6605671
发表时间:
2010
期刊:
British journal of cancer
影响因子:
8.8
作者:
[Peran,I, Riegel,A, Dai,Y, Schlegel,R, Liu,X]
通讯作者:
Liu,X
Conditionally reprogrammed cells as a novel tool for biobanking
-
批准号:8899468
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2013
-
负责人:Richard Schlegel
-
依托单位:
Conditionally reprogrammed cells as a novel tool for biobanking
-
批准号:8727495
-
项目类别:
-
资助金额:$37.14万
-
财政年份:2013
-
负责人:Richard Schlegel
-
依托单位:
Conditionally reprogrammed cells as a novel tool for biobanking
-
批准号:8547303
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2013
-
负责人:Richard Schlegel
-
依托单位:
Emerging Papillomaviruses in Immunosuppressed Dogs
-
批准号:8516613
-
项目类别:
-
资助金额:$39.21万
-
财政年份:2011
-
负责人:Richard Schlegel
-
依托单位:
Emerging Papillomaviruses in Immunosuppressed Dogs
-
批准号:8725249
-
项目类别:
-
资助金额:$41.23万
-
财政年份:2011
-
负责人:Richard Schlegel
-
依托单位:
Emerging Papillomaviruses in Immunosuppressed Dogs
-
批准号:8322566
-
项目类别:
-
资助金额:$39.95万
-
财政年份:2011
-
负责人:Richard Schlegel
-
依托单位:
Emerging Papillomaviruses in Immunosuppressed Dogs
-
批准号:8137493
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2011
-
负责人:Richard Schlegel
-
依托单位:
A topical treatment for genital papillomavirus infections
-
批准号:7286845
-
项目类别:
-
资助金额:$17.99万
-
财政年份:2006
-
负责人:Richard Schlegel
-
依托单位:
A topical treatment for genital papillomavirus infections
-
批准号:7174571
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2006
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:6757107
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:7114631
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:7274152
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
Treatment of Cervical Cancer with Artemisinin
-
批准号:6948533
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:7115758
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:6949542
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
Treatment of Cervical Cancer with Artemisinin
-
批准号:6823604
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
DNA CONFORMATION DEPENDENT REGULATOR OF GENE EXPRESSION
-
批准号:2896082
-
项目类别:
-
资助金额:$23.6万
-
财政年份:1997
-
负责人:Richard Schlegel
-
依托单位:
CANINE ORAL PAPILLOMAVIRUS--MODEL FOR A VACCINE
-
批准号:2098706
-
项目类别:
-
资助金额:$25.16万
-
财政年份:1992
-
负责人:Richard Schlegel
-
依托单位:
CANINE ORAL PAPILLOMAVIRUS--MODEL FOR A VACCINE
-
批准号:2098705
-
项目类别:
-
资助金额:$23.88万
-
财政年份:1992
-
负责人:Richard Schlegel
-
依托单位:
CANINE ORAL PAPILLOMAVIRUS: MODEL FOR A VACCINE
-
批准号:3202287
-
项目类别:
-
资助金额:$23.6万
-
财政年份:1992
-
负责人:Richard Schlegel
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: